In a new book, a science journalist recounts the story of a lifesaving treatment for infection that scientists broadly ...
The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...
Returning to Boston this February, the Bacteriophage Therapy Summit is the only global platform for industry-dominated phage drug developers. Uniting 90+ Chief Executive Officers, Vice Presidents ...
is proud to announce its role in providing bacteriophage therapy for a Canadian patient suffering from a periprosthetic joint infection (PJI) caused by an antimicrobial-resistant (AMR) pathogen.
With the rise of antibiotics in the 1930s, phage therapy (the use of viruses called bacteriophages to fight bacterial infections) was abandoned. Today, the increase in antibiotic resistance makes ...
Urinary tract infections (UTIs), especially cystitis, are a common and frustrating health issue that affects half of all ...
Bacteriophages (T4) were modified with anticancer ... If effective, they can offer a novel strategy for anticancer therapy together with antibacterial protection. Here we present the assessment ...
Bacteriophages, natural "predators" of bacteria, are considered one of the alternatives. The Laboratory for Metagenome Analysis at the Skoltech Bio Center works on the research on bacteriophages ...
is pleased to announce a positive outcome from the first Canadian patient treated with its pioneering bacteriophage (phage) therapy. Six months after receiving the treatment, the patient shows of ...
In order to run PT service for clinicians, safe bacteriophage preparations for therapeutic use approved by appropriate authorities need to be produced and the infrastructure needed for this requires ...
A bacteriophage is a type of virus that infects bacteria. In fact, the word "bacteriophage" literally means "bacteria eater," because bacteriophages destroy their host cells. All bacteriophages ...